Cross-talk between metabolic alterations and stemness acquisition for the progression, severity and therapy of human breast cancer
Author:
Kumari Anjali1, Mishra Rajakishore1
Affiliation:
1. Department of Life Sciences, School of Natural Sciences, Central University of Jharkhand, Ratu-Lohardaga Road, Brambe, Ranchi – 835205, Jharkhand, India.
Abstract
Breast cancer (BC) is the most prevalent gynecological cancer and is the second most reason for cancer-related mortality globally. Various factors like lifestyle, genetics, hormonal/reproductive factors, and carcinogen exposure fuel this neoplasm. These factors act synergistically to drive cancer hallmark characters and alter cellular metabolism. Cancer metabolic reprogramming has been widely acknowledged as a feature of breast neoplasia. Instead, cancer stem cells (CSCs) are a subpopulation of cells with self-renewal, drug resistance, EMT/metastasis potential and recently considered for breast cancer treatment. These CSCs can adjust their metabolism to endure many stress conditions. This chapter discusses breast cancer’s metabolic and stemness networks and associated pathways. Knowledge of altered metabolism and CSCs mechanism is fundamental to BC. This can lead to rewiring the signaling networks and open a new horizon for successful therapeutics in breast cancer.
Publisher
The Applied Biology & Chemistry Journal
Subject
Community and Home Care,Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology,General Medicine,General Medicine,General Medicine,General Medicine,General Medicine,General Earth and Planetary Sciences,General Environmental Science,General Earth and Planetary Sciences,General Environmental Science,General Medicine
Reference157 articles.
1. Ades, F., Zardavas, D., Bozovic-Spasojevic, I., Pugliano, L., et al. (2014). Luminal B breast cancer: Molecular characterization, clinical management, and future perspectives. Journal of Clinical Oncology, 32(25), 2794–2803. https://doi.org/10.1200/jco.2013.54.1870 2. Arundhathi, J. R. D., Mathur, S. R., Gogia, A., Deo, S. V. S., Mohapatra, P., & Prasad, C. P. (2021). Metabolic changes in triple negative breast cancer-focus on aerobic glycolysis. Molecular Biology Reports, 48(5):4733-4745. https://doi.org/10.1007/s11033-021-06414-w 3. Asselin-Labat, M.-L., Vaillant, F., Sheridan, J. M., Pal, B., Wu, D., et al. (2010). Control of mammary stem cell function by steroid hormone signalling. Nature, 465(7299), 798–802. https://doi.org/10.1038/nature09027 4. Atlante, S., Visintin, A., Marini, E., Savoia, M., Dianzani, C., et al. (2018). α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis. Cell Death & Disease, 9(7), 756. https://doi.org/10.1038/s41419-018-0802-8 5. Ayob, A. Z., & Ramasamy, T. S. (2018). Cancer stem cells as key drivers of tumour progression. Journal of Biomedical Science, 25(1), 20. https://doi.org/10.1186/s12929-018-0426-4
|
|